Ankylosing Spondylitis (AS) is a chronic, inflammatory disorder of the spine and sacroiliac joints. It is classified as a type of spondyloarthritis, a group of diseases that affect the spine and other joints. AS is an autoimmune disorder, meaning that the body's immune system mistakenly attacks healthy tissue. Symptoms of AS include pain and stiffness in the lower back and hips, fatigue, and reduced mobility. Treatment options include physical therapy, exercise, and medications such as non-steroidal anti-inflammatory drugs (NSAIDs) and biologic drugs.
The Ankylosing Spondylitis market is a subset of the Allergy and Immunology market. It is a growing market, driven by the increasing prevalence of AS and the development of new treatments. The market is highly competitive, with a number of companies offering treatments for AS.
Some companies in the Ankylosing Spondylitis market include AbbVie, Amgen, Pfizer, and UCB. Show Less Read more
